Neonatal alloimmune thrombocytopenia overview

Revision as of 15:50, 21 September 2012 by Kalsang Dolma (talk | contribs) (Created page with "__NOTOC__ {{ Neonatal Alloimmune Thrombocytopenia}} {{CMG}} ==Overview== '''Neonatal Alloimmune Thrombocytopenia''' is a disease that affects fetuses and [[neo...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Template:Neonatal Alloimmune Thrombocytopenia

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Neonatal Alloimmune Thrombocytopenia is a disease that affects fetuses and newborns. Genetic differences between the fetus and mother may result in the expression of certain antigens by fetal platelets, not expressed by the mother. Fetomaternal transfusions result in the recognition of these antigens by the mother's immune system as non-self, with the subsequence generation of allo-reactive antibodies which cross the placenta. NAIT, hence, is caused by transplacental passage of maternal platelet-specific alloantibody and rarely human leukocyte antigen (HLA) allo-antibodies (which are expressed by platelets) to fetuses whose platelets express the corresponding antigens.

References

Template:WH Template:WS